Dr Clare Hoskins

Reader

Pure and Applied Chemistry

Personal statement

Dr Clare Hoskins is a Reader in the School of Pure and Applied Chemistry. She has published >50 peer reviewed articles and filed 1 patent. Her research has been supported with over £3M by national (e.g. EPSRC, BBSRC/FAPESP, Wellcome Trust) and international (e.g. Newton-Bhabha & British Council, Iraqi Ministry of Higher Education and Scientific Research) research funding. Clare is the Chair of the Royal Society of Chemistry, Chemical Nanosciences and Nanotechnology Network, she is a committee member of the UK and Ireland Controlled Release Society and she sits on the British Council Grant Review Panel for Newton Grants. In 2019 Clare was awarded the Academy of Pharmaceutical Sciences ‘Emerging Scientist’ sponsored by Pfizer and also the North Staffordshire Medical Institute Researcher Award. Clare sits on the editorial board of numerous journals in her field, she leads a vibrant interdisciplinary research group within the them of Bionanotechnology and Analytical Chemistry within the Technology Innovation Centre. The focus of her research is the development of a range of multifunctional nanoparticles and their translation into medical therapies and agricultural products.

Prizes and awards

Strathclyde Medal: Team Award Quilts for Cancer: Recipient; 11/10/2022
Strathclyde medal: team award: Recipient; 11/10/2022
Strathclyde Women in Leadership: Recipient; 2021
North Staffordshire Medical Institute Researcher Award: Recipient; 7/11/2019
Academy of Pharmaceutical Science Emerging Scientist Award: Recipient; 23/9/2019

More prizes and awards

Publications

Quilts 4 cancer : quilting the chemical sciences for pancreatic cancer patients: Ross Kirsty S, Hoskins Clare; Teaching, Research, Innovation and Public Engagement (2023) (2023); https://doi.org/10.1007/978-3-031-22452-2_13
Exploration of nanosilver calcium alginate-based multifunctional polymer wafers for wound healing: Man Ernest, Easdon Claire, McLellan Iain, Yiu Humphrey H P, Hoskins Clare; Pharmaceutics Vol 15 (2023); https://doi.org/10.3390/pharmaceutics15020483
3D printed biodegradable multifunctional implants for effective breast cancer treatment: Di Luca Matteo, Hoskins Clare, Corduas Francesca, Onchuru Rachel, Oluwasanmi Adeolu, Mariotti Davide, Conti Bice, Lamprou Dimitrios A; International Journal of Pharmaceutics Vol 629 (2022); https://doi.org/10.1016/j.ijpharm.2022.122363
Liposome-based diagnostic and therapeutic applications for pancreatic cancer: Raza Faisal, Evans Lauren, Motallebi Mahzad, Zafar Hajra, Pereira-Silva Miguel, Saleem Kalsoom, Peixoto Diana, Rahdar Abbas, Sharifi Esmaeel, Veiga Fransisco, Hoskins Clare, Paiva-Santos Ana Cláudia; Acta Biomaterialia (2022); https://doi.org/10.1016/j.actbio.2022.12.013
Exploration of dual ionic cross-linked alginate hydrogels via cations of varying valences towards wound healing: Man Ernest, Lamprou Dimitrios, Easdon Claire, McLellan Iain, Yiu Humphrey H P, Hoskins Clare; Polymers Vol 14 (2022); https://doi.org/10.3390/polym14235192
Ag nanostructure morphologies and physicochemical properties dictated by the polyols used in the synthesis: Sharif Sadia, Ahmad Zahoor, Hoskins Clare, Choudhary Muhammad Aziz, Mehmood Arshad; Journal of Nano Research Vol 76, pp. 93-106 (2022); https://doi.org/10.4028/p-c41elh

More publications

Professional activities

Nano-assasins for pancreatic cancer therapy: Speaker; 22/2/2022
The Big Impact of Small for Pancreatic Cancer: Speaker; 28/1/2022
Controlled Release Society , USA: Participant; 2022
RSC Chemical Nanosciences and Nanotechnology Network Annual Symposium: Participant; 2022
Pancreatic Nano-ninjas: Speaker; 29/11/2021
Nano-assasins for pancreatic cancer therapy: Speaker; 29/10/2021

More professional activities

Projects

NextPharma PhD studentship for Healthcare Nanotechnologies CDT: Hoskins, Clare (Principal Investigator); 01-Jan-2022 - 31-Jan-2026
Second generation precision nano-carriers for pancreatic cancer (Undergraduate Vacation Scholarship): Hoskins, Clare (Principal Investigator); 18-Jan-2022 - 26-Jan-2022
IRC - Targeted Delivery of Hard-to-Treat Cancers - Project Partner: Hoskins, Clare (Principal Investigator); 01-Jan-2022 - 29-Jan-2024
Validation of use of femtosecond lasers in the nanotechnology market: Hoskins, Clare (Principal Investigator); 01-Jan-2021 - 28-Jan-2022
Doctoral Training Partnership 2020-2021 University of Strathclyde | Taysum, Hannah: Wark, Alastair (Principal Investigator) Hoskins, Clare (Co-investigator) Taysum, Hannah (Research Co-investigator); 01-Jan-2021 - 01-Jan-2025
Multiscale Metrology Suite for Next-generation Healthcare Technologies (EPSRC Strategic Equipment): Rattray, Zahra (Principal Investigator) Bruns, Nico (Co-investigator) Faulds, Karen (Co-investigator) Graham, Duncan (Co-investigator) Halbert, Gavin (Co-investigator) Hoskins, Clare (Co-investigator) McArthur, Stephen (Co-investigator) Perrie, Yvonne (Co-investigator) Reid, Stuart (Co-investigator) Seib, Philipp (Co-investigator); 01-Jan-2021 - 31-Jan-2024

More projects

Address

Pure and Applied Chemistry
Technology Innovation Centre

Location Map

View University of Strathclyde in a larger map